Mersana Therapeutics, Inc.
Developing innovative antibody-drug conjugates using proprietary platforms to treat cancer.
MRSN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US59045L1061
- LEI:
- Country:
- United States of America
- Address:
- 840 MEMORIAL DRIVE, 2139 CAMBRIDGE
- Website:
- https://www.mersana.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing life-changing antibody-drug conjugates (ADCs) for patients with cancer. The company utilizes its proprietary and innovative ADC platforms, which employ both cytotoxic and immunostimulatory payloads. These platforms are designed to overcome the limitations of first-generation ADCs by allowing for the customization and optimization of therapies to improve efficacy and tolerability. Mersana is advancing a pipeline of ADCs that target multiple tumor types with high unmet medical needs, aiming to provide meaningful benefits to people fighting cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Mersana Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mersana Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mersana Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
